Befejeződött1. fázis
To Evaluate the Safety and Pharmacokinetics of XMAB24306 in Combination with Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma
Key facts
- Where
- Badalona, Barcelona, Girona, L'Hospitalet de Llobregat, Madrid, Pozuelo de Alarcón, Salamanca, Sevilla és Valencia, SpanyolországSee the 11 sites
- Phase
- 1. fázis
Where in Spanyolország
- Hospital Germans Trias i PujolBadalona, SpanyolországNo longer taking part
- Hospital Clinic de BarcelonaBarcelona, SpanyolországNo longer taking part
- Hospital de la Santa Creu i Sant PauBarcelona, SpanyolországNo longer taking part
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
- Institut Català d'OncologiaGirona, SpanyolországNo longer taking part
- Institut Catala D'oncologiaL'Hospitalet de Llobregat, SpanyolországNo longer taking part
- Hospital Universitario de la PrincesaMadrid, SpanyolországNo longer taking part
- Hospital Universitario Quironsalud MadridPozuelo de Alarcón, SpanyolországNo longer taking part
- Hospital Universitario De SalamancaSalamanca, SpanyolországNo longer taking part
- University Hospital Virgen Del Rocio S.L.Sevilla, SpanyolországNo longer taking part
- Hospital Universitario Y Politecnico La FeValencia, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Genentech Inc.
- Trial code
- EU 2024-510644-31-00
- Record updated
- 2024. április 22.